Quoin Pharmaceuticals, Ltd. (QNRX)
$4.10-1.20%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Beta
- 1.66
- P/E (TTM)
- -0.27
- Short % float
- 4.54%
- Days to cover
- 1.4
- SI change
- -48.2%
- 1W
- -12.77%
- 1M
- -39.71%
- vs SPY 1W
- -11.79%
- vs SPY 1M
- -41.57%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on QNRX?
- LOPJLB’s latest quantitative signal on Quoin Pharmaceuticals, Ltd. (QNRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is QNRX in?
- Quoin Pharmaceuticals, Ltd. (QNRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Quoin Pharmaceuticals, Ltd. (QNRX) do?
- Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX00…